Presence of soluble amyloid β–peptide precedes amyloid plaque formation in Down's syndrome
暂无分享,去创建一个
D. Mann | M. Tabaton | L. Debusk | P. Gambetti | S. Bertolini | C. Russo | G. Angelini | J. Teller | D. Zaccheo | F. Dagna-Bricarelli | P. Scartezzini
[1] N. Suzuki,et al. Long amyloid beta-protein secreted from wild-type human neuroblastoma IMR-32 cells. , 1995, Biochemistry.
[2] A. Odaka,et al. Amyloid β protein 1–42/43 (Aβ 1–42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study , 1995, Brain Research.
[3] S. Younkin,et al. Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). , 1995, The Journal of biological chemistry.
[4] D. Mann,et al. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome , 1995, Annals of neurology.
[5] N. Suzuki,et al. Biochemical evidence for the long-tail form (Aβ1-42/43) of amyloid β protein as a seed molecule in cerebral deposits of alzheimer′s disease , 1994 .
[6] S. Younkin,et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.
[7] M. Tabaton,et al. Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. , 1994, Biochemical and biophysical research communications.
[8] S. Younkin,et al. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. , 1993, Science.
[9] D. Selkoe,et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.
[10] D. Graham,et al. βA4 amyloid protein deposition in brain after head trauma , 1991, The Lancet.
[11] PhilipR. Wenham,et al. Apolipoprotein E genotyping by one-stage PCR , 1991, The Lancet.
[12] J. Reed,et al. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease , 1991 .
[13] R. Martins,et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. , 1989, The New England journal of medicine.
[14] H. Schägger,et al. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.
[15] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[16] H. Wiśniewski,et al. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome , 1985, Annals of neurology.
[17] S. Hirai,et al. Immunohistochemical analysis of COOH-termini of amyloid beta protein (Aβ) using end-specific antisera for Aβ40 and Aβ42 in Alzheimer's disease and normal aging , 1995 .
[18] D. Selkoe,et al. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. , 1994, Annual review of cell biology.
[19] D. Selkoe,et al. Normal and abnormal biology of the beta-amyloid precursor protein. , 1994, Annual review of neuroscience.